Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center
Advertisement
Articles by Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center
Advertisement
Latest Updated Articles
Available Staging Systems for Cutaneous Squamous Cell CarcinomaPublished: March 15th 2023 | Updated:
Cutaneous Squamous Cell Carcinoma: Incidence and Risk FactorsPublished: March 15th 2023 | Updated:
Dr. Luke on Current and Emerging Treatment Approaches in Metastatic MelanomaPublished: January 7th 2020 | Updated:
Dr. Luke on Predictive Biomarkers in Metastatic MelanomaPublished: February 20th 2020 | Updated:
Identifying Patients for Neoadjuvant Melanoma TherapyPublished: June 23rd 2020 | Updated:
Systemic Therapy for Metastatic MelanomaPublished: June 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5